These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 23651945

  • 1. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M, Hausner L, Jekel K, Richter M, Froelich L, Almkvist O, Boada M, Bullock R, De Deyn PP, Frisoni GB, Hampel H, Jones RW, Kehoe P, Lenoir H, Minthon L, Olde Rikkert MG, Rodriguez G, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Verhey FR, Winblad B, Wahlund LO, Wilcock G, Visser PJ.
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [Abstract] [Full Text] [Related]

  • 2. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Frisoni GB, Froelich L, Nobili F, van der Flier W, Blennow K, Wolz R, Scheltens P, Visser PJ.
    Neurology; 2013 Mar 19; 80(12):1124-32. PubMed ID: 23446677
    [Abstract] [Full Text] [Related]

  • 3. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT, Janowitz D, Kilimann I, Laske C, Menne F, Nestor P, Peters O, Priller J, Pross V, Ramirez A, Schneider A, Speck O, Spruth EJ, Teipel S, Vukovich R, Westerteicher C, Wiltfang J, Wolfsgruber S, Wagner M, Düzel E.
    Alzheimers Res Ther; 2018 Feb 07; 10(1):15. PubMed ID: 29415768
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
    Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Bürger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K.
    Lancet Neurol; 2009 Jul 07; 8(7):619-27. PubMed ID: 19523877
    [Abstract] [Full Text] [Related]

  • 5. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P, Brousseau M, Chertkow H, Phillips N, Nasreddine ZS.
    J Am Geriatr Soc; 2014 Apr 07; 62(4):679-84. PubMed ID: 24635004
    [Abstract] [Full Text] [Related]

  • 6. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA, Visser PJ, Knol DL, van der Flier WM, Teunissen CE, Barkhof F, Blankenstein MA, Scheltens P.
    J Alzheimers Dis; 2012 Apr 07; 29(2):319-27. PubMed ID: 22233766
    [Abstract] [Full Text] [Related]

  • 7. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M.
    J Alzheimers Dis; 2013 Apr 07; 34(3):665-72. PubMed ID: 23254639
    [Abstract] [Full Text] [Related]

  • 8. [Subjective cognitive impairment and Alzheimer's disease: a two year follow up of 51 subjects during two years].
    Sambuchi N, Muraccioli I, Alescio-Lautier B, Paban V, Sambuc R, Jouve É, Geda YE, Petersen RK, Michel BF.
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Dec 07; 13(4):462-71. PubMed ID: 26707564
    [Abstract] [Full Text] [Related]

  • 9. Serial position effects in patients with mild cognitive impairment and early and moderate Alzheimer's disease compared with healthy comparison subjects.
    Moser B, Deisenhammer EA, Marksteiner J, Papousek I, Fink A, Weiss EM.
    Dement Geriatr Cogn Disord; 2014 Dec 07; 37(1-2):19-26. PubMed ID: 24107650
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O, Alzheimer’s Disease Neuroimaging Initiative.
    JAMA Psychiatry; 2014 Oct 07; 71(10):1183-91. PubMed ID: 25162367
    [Abstract] [Full Text] [Related]

  • 11. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A, Alegret M, Pesini P, Valero S, Lafuente A, Buendía M, San José I, Ibarria M, Tejero MA, Giménez J, Ruiz S, Hernández I, Pujadas F, Martínez-Lage P, Munuera J, Arbizu J, Tárraga L, Hendrix SB, Ruiz A, Becker JT, Landau SM, Sotolongo-Grau O, Sarasa M, Boada M, AB255 Study Group, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2017 Oct 07; 57(2):447-459. PubMed ID: 28269787
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.
    Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L'Italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ.
    Neurobiol Aging; 2012 Oct 07; 33(10):2272-81. PubMed ID: 22264648
    [Abstract] [Full Text] [Related]

  • 14. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA, Pua EP, Zhou J, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2015 Oct 07; 45(1):253-68. PubMed ID: 25524955
    [Abstract] [Full Text] [Related]

  • 15. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M.
    J Alzheimers Dis; 2015 Oct 07; 44(2):625-33. PubMed ID: 25322924
    [Abstract] [Full Text] [Related]

  • 16. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test.
    Bolló-Gasol S, Piñol-Ripoll G, Cejudo-Bolivar JC, Llorente-Vizcaino A, Peraita-Adrados H.
    Neurologia; 2014 Oct 07; 29(6):339-45. PubMed ID: 24139389
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BN, Simmons A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Muscio C, Herukka SK, Salmon E, Bastin C, Wallin A, Nordlund A, de Mendonça A, Silva D, Santana I, Lemos R, Engelborghs S, Van der Mussele S, Alzheimer’s Disease Neuroimaging Initiative, Freund-Levi Y, Wallin ÅK, Hampel H, van der Flier W, Scheltens P, Visser PJ.
    Brain; 2015 May 07; 138(Pt 5):1327-38. PubMed ID: 25693589
    [Abstract] [Full Text] [Related]

  • 18. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.
    J Intern Med; 2004 Sep 07; 256(3):205-23. PubMed ID: 15324364
    [Abstract] [Full Text] [Related]

  • 19. Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Gainotti G, Quaranta D, Vita MG, Marra C.
    J Alzheimers Dis; 2014 Sep 07; 38(3):481-95. PubMed ID: 24002185
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.